| Intermittent Hypoxia Elicits Prolonged Restoration of Motor Function in Human SCI (NCT01272349) | Emory University | 2010-12-01 |
| A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors (NCT01263223) | Eli Lilly and Company | 2010-12-01 |
| A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma (NCT01212276) | Morphotek | 2010-12-01 |
| A Study of LY2216684 and Digoxin in Healthy Subjects (NCT01266590) | Eli Lilly and Company | 2010-12-01 |
| Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer (NCT01274624) | Oncolytics Biotech | 2010-12-01 |
| An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84 (NCT01296386) | Valneva Austria GmbH | 2010-12-01 |
| LY2189265 and Atorvastatin Interaction Study (NCT01250834) | Eli Lilly and Company | 2010-12-01 |
| Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL (NCT01217749) | Pharmacyclics LLC. | 2010-12-01 |
| Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia (NCT01251250) | Roswell Park Cancer Institute | 2010-12-01 |
| Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia (NCT01297205) | Medipost Co Ltd. | 2010-12-01 |
| The Effect of Femoral Nerve Block on Postoperative Opioid Use After Anterior Cruciate Ligament (ACL) Reconstruction (NCT00175630) | University of British Columbia | 2010-12-01 |
| Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects (NCT01396590) | Eisai Inc. | 2010-12-01 |
| Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma (NCT01330173) | National Cancer Institute (NCI) | 2010-12-01 |
| Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan (NCT01251835) | Pfizer | 2010-12-01 |
| Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas (NCT01258868) | National Cancer Institute (NCI) | 2010-12-01 |
| Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana Vitrectomy (NCT01229410) | Allergan | 2010-12-01 |
| A Study of [11C]JNJ-42491293, a Possible PET Ligand for the mGlu2 Receptor, in Healthy Adult Volunteers (NCT01359852) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-12-01 |
| Melanocyte Transplantation for Patients With Stable Vitiligo. (NCT01701648) | Clinica Universidad de Navarra, Universidad de Navarra | 2010-12-01 |
| Safety and Efficacy Study of Human Autologous Hair Follicle Cells to Treat Androgenetic Alopecia (NCT01286649) | TrichoScience Innovations, Inc. | 2010-12-01 |
| PAC-14028 in Healthy Male Volunteers (NCT01264224) | Amorepacific Corporation | 2010-12-01 |
| Study to Evaluate the Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Elderly Subjects (NCT01274598) | Massachusetts General Hospital | 2010-12-01 |
| Tissue Distribution of F18-FDG Labeled ABMSCT in Patients With Type2 Diabetes Mellitus (NCT02585505) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2010-12-01 |
| Evaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation. (NCT01290172) | University Hospital, Ghent | 2010-12-01 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort (NCT01294540) | Eisai Inc. | 2010-12-01 |
| Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults (NCT01274429) | University of North Carolina, Chapel Hill | 2010-12-01 |
| Study Effects of Intermittent Hypoxia on Restoring Hand Function Following SCI (NCT01272336) | Emory University | 2010-12-01 |
| Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis (NCT01044381) | Topica Pharmaceuticals | 2010-12-01 |
| A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors (NCT01277146) | OncoMed Pharmaceuticals, Inc. | 2010-12-01 |
| Pharmacokinetics of 9-cis-retinoic Acid (Alitretinoin, Toctino®) in Patients With Hepatic Disease (NCT01261923) | University Hospital, Gentofte, Copenhagen | 2010-12-01 |
| Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz (NCT01458769) | Concert Pharmaceuticals | 2010-12-01 |
| Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults (NCT01263691) | Emergent BioSolutions | 2010-12-01 |
| Open-label, Normal Healthy Volunteer Clinical Trial of a Novel Ondansetron Formulation (NCT01290276) | Tong Lee | 2010-12-01 |
| A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects (NCT01299454) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2010-12-01 |
| Demonstrate Bioequivalence Between 3 x 2-mg Tablets of Perampanel and a Single 6-mg Tablet of Perampanel in Healthy Subjects (NCT01396577) | Eisai Inc. | 2010-12-01 |
| A Study of ARQ 197 in Combination With Erlotinib (NCT01251796) | Kyowa Kirin Co., Ltd. | 2010-12-01 |
| Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer (NCT01238133) | National Cancer Institute (NCI) | 2010-12-01 |
| Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients (NCT01257776) | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | 2010-12-01 |
| Biodistribution and Dosimetry Evaluation of [124I]FIAU (NCT01337466) | BioMed Valley Discoveries, Inc | 2010-12-01 |
| A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin (NCT01238796) | Cumberland Pharmaceuticals | 2010-12-01 |
| Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients (NCT01236378) | Pfizer | 2010-12-01 |
| Bosentan for Severe Mitral Valve Dysfunction (NCT01270750) | General Hospital of Chalkida | 2010-12-01 |
| Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis (NCT01289951) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2010-12-01 |
| Closed Loop System With Pramlintide Versus Exenatide (NCT01269008) | Albert Einstein College of Medicine | 2010-12-01 |
| Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose (NCT01300988) | University of Pennsylvania | 2010-12-01 |
| Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer (NCT01222572) | Dana-Farber Cancer Institute | 2010-12-01 |
| Phase 1 and 2 Study of PX-866 and Cetuximab (NCT01252628) | Cascadian Therapeutics Inc. | 2010-12-01 |
| Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) (NCT01295593) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2010-12-01 |
| Phase I of OratecanTM in Combination With Capecitabine in Patients With Advanced Solid Malignancies (NCT01463982) | Hanmi Pharmaceutical Company Limited | 2010-12-01 |
| Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery (NCT01267331) | Chinese PLA General Hospital | 2010-12-01 |
| Study to Evaluate Safety and Toxicity of Polyphenon E (EGCG) in HIV-1-Infected Individuals (NCT01433289) | Baylor College of Medicine | 2010-12-01 |
| Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly (NCT01304771) | Mayo Clinic | 2010-12-01 |
| Determine the Effect of AZD3161,Injected Intradermally, on Quantitative Sensory Testing Variables in Normal and Ultraviolet-C (UVC) Exposed Skin in Healthy Volunteers (NCT01240148) | AstraZeneca | 2010-12-01 |
| Amgen 386 for Recurrent Glioblastoma (NCT01290263) | Dana-Farber Cancer Institute | 2010-12-01 |
| A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers (NCT01259882) | Pfizer | 2010-12-01 |
| A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine (NCT01268787) | National Health Research Institutes, Taiwan | 2010-12-01 |
| Clinical Trial of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine (NCT01263327) | Xiamen University | 2010-12-01 |
| A Safety Study of LY2886721 Multiple Doses in Healthy Subjects (NCT01227252) | Eli Lilly and Company | 2010-12-01 |
| Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer (NCT01291615) | Kansai Hepatobiliary Oncology Group | 2010-12-01 |
| Gemcitabine/Cisplatin/S-1(GCS) Combination Therapy for Patients With Advanced Biliary Tract Cancer (NCT01284413) | Kansai Hepatobiliary Oncology Group | 2010-12-01 |
| A Double-Blind Study in Healthy Volunteers to Assess the Effect of E7080 on the QTc Interval (NCT01525394) | Eisai Inc. | 2010-12-01 |
| In Vivo Assessment of Silver Biomaterial Nano-Toxicity (NCT01243320) | University of Utah | 2010-12-01 |
| Safety and Tolerability Study for Age-Related Macular Degeneration (NCT01485588) | Iconic Therapeutics, Inc. | 2010-12-01 |
| A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies (NCT01317927) | Spectrum Pharmaceuticals, Inc | 2010-12-01 |
| Dexmedetomidine in Seizure Patients (NCT01116700) | University of California, San Francisco | 2010-12-01 |
| A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel (NCT01263093) | Eli Lilly and Company | 2010-12-01 |
| Phase l/II Study of Ruxolitinib for Acute Leukemia (NCT01251965) | M.D. Anderson Cancer Center | 2010-12-01 |
| Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food. (NCT01254396) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-12-01 |
| A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol (NCT01263197) | Eli Lilly and Company | 2010-12-01 |
| Clinical Study to Evaluate Safety and Maximum Tolerated Dose of BAY1000394 Given in a 4 Week on / 2 Week Off Schedule in Subjects With Advanced Malignancies (NCT01335256) | Bayer | 2010-12-01 |
| Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine (NCT01290419) | Novavax | 2010-12-01 |
| Safety Study of Three Formulations of the Dermal Implant ELAPR (NCT01467778) | Elastagen Pty Ltd | 2010-12-01 |
| Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors (NCT01240538) | National Cancer Institute (NCI) | 2010-12-01 |
| A Study of Brain Receptor Occupancy in Healthy Subjects (NCT01232439) | Eli Lilly and Company | 2010-12-01 |
| A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers (NCT01261754) | Molecular Insight Pharmaceuticals, Inc. | 2010-12-01 |
| Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults (NCT01273233) | Sinovac Biotech Co., Ltd | 2010-12-01 |
| A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG) (NCT01166412) | Premier Research | 2010-12-01 |
| Bosutinib In Subjects With Renal Impairment (NCT01233882) | Pfizer | 2010-12-01 |
| A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke) (NCT01273467) | Janssen Research & Development, LLC | 2010-12-01 |
| A Study of LY2216684 and Theophylline in Healthy Subjects (NCT01263106) | Eli Lilly and Company | 2010-12-01 |
| Bioequivalence Study of Metoprolol Succinate ER Tablets, 200 mg Under Fasting Conditions (NCT01673997) | Dr. Reddy's Laboratories Limited | 2010-12-01 |
| Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor (NCT01324492) | Novartis Pharmaceuticals | 2010-12-01 |
| Early Embryo Cleavage And Multiple Pregnancies After ICSI (NCT02265055) | Al-Azhar University | 2010-12-01 |
| Gene Therapy for X-linked Severe Combined Immunodeficiency (NCT01410019) | Assistance Publique - Hôpitaux de Paris | 2010-12-01 |
| Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer (NCT01199367) | Kyowa Kirin Co., Ltd. | 2010-12-01 |
| A Study of LY2940094 in Major Depressive Disorder (NCT01263236) | BlackThorn Therapeutics, Inc. | 2010-12-01 |
| Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study (NCT01213810) | University of Zurich | 2010-12-01 |
| Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) in Healthy, Normal Subjects (NCT01265745) | PharmAthene, Inc. | 2010-12-01 |
| Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules (NCT01226316) | AstraZeneca | 2010-12-01 |
| Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. (NCT01229280) | Center for Clinical Pharmacology Research Bdbeq S.A. | 2010-12-01 |
| A Study to Compare the Bioequivalence of 50-mg Tapentadol (CG5503) Dose Administered as Two 50-mg Tablets Relative to One 100-mg Tablet (NCT01273532) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-12-01 |
| Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients (NCT01202591) | AstraZeneca | 2010-12-01 |
| A Study of the Effect of LY2216684 on Lorazepam (NCT01275144) | Eli Lilly and Company | 2010-12-01 |
| A Study to Evaluate Sildenafil for the Treatment of Lymphatic Malformations (NCT01290484) | Stanford University | 2010-12-01 |
| Assess the Safety and Adhesive Performance of the VIPER System When Compared to Esteem™ (NCT01261988) | ConvaTec Inc. | 2010-12-01 |
| Determine MTD and to Evaluate pk, Safety/Tolerability and Efficacy Profiles of Hocena® in NSCLC Subjects (NCT01134016) | Golden Biotechnology Corporation | 2010-12-01 |
| A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction (NCT01273493) | Janssen Research & Development, LLC | 2010-12-01 |
| Single Ascending Doses of GGF2 in Patients With Left Ventricular Dysfunction and Symptomatic Heart Failure (NCT01258387) | Acorda Therapeutics | 2010-12-01 |
| A Study In Japanese Healthy Male Volunteers To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-02341066 (NCT01250730) | Pfizer | 2010-12-01 |
| Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia (NCT01260714) | National Cancer Institute (NCI) | 2010-12-01 |
| A Study of LY2216684 and Warfarin in Healthy Subjects (NCT01263119) | Eli Lilly and Company | 2010-12-01 |